Cortexa

Cortexa is a two-blend delayed-release capsule formulation targeting cognitive function through complementary neuroprotective and neurotransmitter pathways.

VITAMINS: Vitamin B6 (as pyridoxine HCl) — essential cofactor for neurotransmitter synthesis (serotonin, dopamine, GABA, norepinephrine). Vitamin B12 (as methylcobalamin) — supports myelin sheath maintenance and neurological function; active methylated form for direct utilisation.

NEUROPRO-AUTOPHAGY SUPPORT BLEND: Micronized Curcumin (NovoCurmin™ technology) — neuroprotective; helps support healthy inflammatory response in neural tissue via NF-κB modulation. Shilajit extract (Mumijo) — fulvic acid complex; helps support mitochondrial electron transport efficiency and cellular energy in the brain. Micronized Saffron extract (crocin/safranal) — published RCTs showing support for healthy mood and cognitive function; serotonergic modulation. Micronized Trans-Resveratrol — sirtuin activator; helps support cellular autophagy and neuroprotection; crosses blood-brain barrier. Nicotinamide Mononucleotide (NMN) — NAD⁺ precursor; helps support cellular energy metabolism in neurons; NAD⁺ decline is associated with neurodegeneration. Micronized Pyrroloquinoline Quinone (PQQ) — helps support mitochondrial biogenesis (creation of new mitochondria); potent antioxidant; published human studies on cognitive function.

NEUROTRANSMIT-SUPPORT BLEND: Trimethylglycine (TMG/Betaine) — methyl donor; helps support SAM-e cycle and neurotransmitter methylation; supports homocysteine recycling. Micronized Huperzia Serrata extract (Huperzine A) — reversible acetylcholinesterase inhibitor; helps support acetylcholine availability for memory and learning.

OTHER INGREDIENTS: Delayed release capsule (Red iron oxide, Hypromellose, Gellan gum), Polysorbate 80, Colloidal Silicon Dioxide, Maltodextrin, Stearic Acid.

BLOOD-BRAIN BARRIER CHALLENGE: The brain is protected by the blood-brain barrier (BBB) — a highly selective membrane that blocks most compounds from entering neural tissue. Many nootropic ingredients fail because they cannot cross the BBB in meaningful quantities. Micro Matrix Technology addresses this through multiple mechanisms.

MICRONIZED CURCUMIN: Standard curcumin has negligible brain penetration. NovoCurmin's micronized, self-emulsifying format increases systemic bioavailability (89 mg/mL solubility), which in turn increases the concentration gradient driving BBB penetration. Published research shows curcumin can cross the BBB when adequate plasma levels are achieved.

MICRONIZED RESVERATROL: Trans-resveratrol is known to cross the BBB but has extremely poor oral bioavailability (<1% standard). Micronization + self-emulsifying matrix dramatically increases systemic levels, providing more compound available for BBB transport.

MICRONIZED PQQ: PQQ is a redox cofactor that supports mitochondrial biogenesis. Micronization ensures adequate absorption for this low-dose, high-value compound. Published human studies (Itoh et al., 2016) show cognitive benefits at supplemental doses.

MICRONIZED HUPERZINE A: Huperzine A naturally crosses the BBB (it's a small alkaloid). Micronization in Cortexa ensures consistent dissolution and absorption so that predictable plasma levels reach the brain. This is critical because Huperzine A has a specific pharmacological mechanism (AChE inhibition) that requires consistent dosing.

DELAYED-RELEASE RATIONALE: Protects acid-sensitive compounds (NMN, PQQ) from stomach degradation. Releases in the small intestine for optimal absorption. The delayed release also provides a more sustained absorption profile rather than a sharp peak-and-crash.

PATHWAY 1 — NEUROPROTECTIVE AUTOPHAGY (Long-term brain health): Cellular autophagy (self-cleaning) declines with age in neural tissue, contributing to accumulation of damaged proteins (amyloid, tau) and dysfunctional mitochondria. Curcumin supports autophagy-related signalling via mTOR modulation. Resveratrol activates SIRT1, which promotes autophagy and mitochondrial quality control. NMN provides NAD⁺ precursor support for sirtuin-mediated autophagy activation. PQQ stimulates mitochondrial biogenesis — creating new, healthy mitochondria to replace damaged ones. Shilajit's fulvic acid complex supports mitochondrial electron transport chain efficiency.

PATHWAY 2 — NEUROTRANSMITTER OPTIMISATION (Immediate cognitive performance): Huperzine A is a reversible acetylcholinesterase inhibitor — it helps maintain acetylcholine levels by slowing its enzymatic breakdown. Acetylcholine is the primary neurotransmitter for memory formation, attention, and learning. TMG (Betaine) provides methyl groups for the SAM-e cycle, which is essential for neurotransmitter synthesis (dopamine, serotonin, norepinephrine methylation). B6 is a direct cofactor in the synthesis of serotonin (from tryptophan), dopamine (from tyrosine), and GABA (from glutamate). B12 supports myelin sheath integrity — the insulation around nerve fibres that determines signal transmission speed. Saffron (crocin/safranal) modulates serotonergic signalling — published RCTs show mood and cognitive benefits.

SYNERGISTIC DESIGN: The two pathways work on different timescales. The NeuroPro-Autophagy blend targets long-term neuroprotection and cellular maintenance (weeks-months). The NeuroTransmit blend targets more immediate neurotransmitter availability (hours-days). Together they address both structural brain health and functional cognitive performance — a distinction most nootropic products miss.

HUPERZINE A: Published human studies showing cognitive support. Zhang et al. (2002): meta-analysis of RCTs showing memory improvement. Mechanism: reversible AChE inhibition (same class as donepezil but from a botanical source). Important: has drug-like activity — position carefully to avoid drug claims.

SAFFRON (Crocin/Safranal): Multiple published RCTs. Akhondzadeh et al. (2010): saffron comparable to donepezil for mild-to-moderate cognitive support in a 22-week RCT. Hausenblas et al. (2013): meta-analysis confirming mood support effects. Mechanism: serotonergic modulation, antioxidant, anti-inflammatory.

PQQ (Pyrroloquinoline Quinone): Published human studies. Itoh et al. (2016): PQQ supplementation improved cognitive function scores in middle-aged and elderly subjects. Mechanism: mitochondrial biogenesis stimulation via PGC-1α activation; potent antioxidant (5,000× more redox cycling capacity than vitamin C).

CURCUMIN: Extensive neuroprotection literature. Cox et al. (2015): curcumin improved working memory and attention in healthy older adults. Mechanism: NF-κB modulation, amyloid aggregation inhibition, neurogenesis support via BDNF. Note: bioavailability is critical — NovoCurmin addresses this.

TRANS-RESVERATROL: Published evidence on cerebrovascular function. Kennedy et al. (2010): resveratrol increased cerebral blood flow in humans. Mechanism: SIRT1 activation, eNOS upregulation, anti-inflammatory. Note: crosses BBB but requires adequate plasma levels — Micro Matrix micronization is essential.

SHILAJIT: Traditional use evidence plus emerging clinical data. Cornejo et al. (2011): fulvic acid prevents tau aggregation in vitro. Mechanism: mitochondrial electron transport support, antioxidant. Evidence level: preliminary but promising.

NMN: Emerging human data on NAD⁺ replenishment. Brain NAD⁺ decline is associated with cognitive aging. Mechanism: NAD⁺ precursor supporting sirtuin activity and DNA repair in neurons.

APPROVED CLAIMS: 'Supports cognitive function and mental clarity' | 'Designed to support neuroprotective pathways' | 'Contains ingredients that may help support healthy brain aging' | 'Formulated with Micro Matrix Technology for enhanced delivery' | 'Contains B vitamins that contribute to normal neurological function' | 'Dual-pathway approach to cognitive wellness' | 'Contains clinically studied cognitive support ingredients'

PROHIBITED CLAIMS: 'Treats or prevents Alzheimer's disease' | 'Treats dementia or cognitive decline' | 'Equivalent to prescription nootropics or cholinesterase inhibitors' | 'Guaranteed memory improvement' | 'FDA approved for any condition' | 'Cures brain fog' | 'Smart drug' | 'Prevents neurodegeneration' | 'Reverses cognitive decline'

HUPERZINE A — SPECIAL CAUTION: Because Huperzine A has a specific pharmacological mechanism (acetylcholinesterase inhibition — the same mechanism as prescription drugs like donepezil/Aricept), extra care is needed. NEVER position it as treating Alzheimer's, dementia, or any cognitive disorder. The compliant framing is: 'helps support acetylcholine availability for memory and learning.'

SOCIAL MEDIA GUIDANCE: Focus on 'cognitive support' and 'mental clarity' language. Share ingredient-level published studies with proper citations. Never promise specific cognitive improvements or compare to prescription medications. The dual-pathway (protection + performance) story is compelling without making drug claims.

Key takeaway: Cortexa supports cognitive function through neuroprotective and neurotransmitter pathways. It does NOT treat, prevent, or cure any neurological disease. The Huperzine A mechanism is real and published but must be framed as 'supports acetylcholine availability' — never as treating any condition.

Required FDA Disclaimer: 'These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.'